In pediatric‐onset PAH, rare deleterious variants in SOX17 are significant genetic contributors, distinct from adult‐onset PAH, and associated with developmental origins of the disease [82, 83, 84, 85]. Here, SOX17 is linked to pulmonary arterial hypertension.